The FDA is pushing for a voluntary recall of certain lots of extended-release metformin after lab tests revealed unacceptable levels of N-nitrosodimethylamine.

Rosiglitazone was once a popular treatment for Type 2 diabetes, but it fell out of favor due to a variety of side effects.

Welldoc, a Columbia, Maryland-based digital health company, has gained an additional FDA approval for its BlueStar diabetes management solution.

Limiting saturated fat intake can decrease a person’s risk of adverse cardiovascular events by a significant margin, according to a new systematic review of 15 different studies.

Drinking just one sugary drink per day can increase a woman’s risk of cardiovascular disease (CVD) by 19%, according to new findings published in the Journal of the American Heart Association.

As COVID-19 patients begin to bounce back, they are sure to have plenty of important questions about the recovery process. 

Substituting butter, margarine, mayonnaise or dairy fat with olive oil can lower a person’s risk of coronary heart disease (CHD) and total cardiovascular disease (CVD), according to new research published in the Journal of the American College of Cardiology.

Taking evolocumab to lower LDL cholesterol can lead to significant reductions in a patient’s risk of myocardial infarction (MI), according to new findings published by JAMA Cardiology.